Alnylam Pharmaceuticals (ALNY) EBIT (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 103.95% |
| Dec 31, 2025 | -64.21% |
| Sep 30, 2025 | 2,371.63% |
| Jun 30, 2025 | -189.61% |
| Mar 31, 2025 | 117.19% |
| Dec 31, 2024 | -36.74% |
| Sep 30, 2024 | -258.20% |
| Jun 30, 2024 | 211.92% |
| Mar 31, 2024 | 62.69% |
| Dec 31, 2023 | -154.43% |
| Sep 30, 2023 | 193.05% |
| Jun 30, 2023 | -53.42% |
| Mar 31, 2023 | 20.57% |
| Dec 31, 2022 | 26.91% |
| Sep 30, 2022 | -34.62% |
| Jun 30, 2022 | -30.64% |
| Mar 31, 2022 | 24.58% |
| Dec 31, 2021 | -7.09% |
| Sep 30, 2021 | -24.30% |
| Jun 30, 2021 | 21.53% |
| Mar 31, 2021 | 4.10% |
| Dec 31, 2020 | 13.76% |
| Sep 30, 2020 | -13.25% |
| Jun 30, 2020 | 5.38% |
| Mar 31, 2020 | 29.49% |
| Dec 31, 2019 | -37.81% |
| Sep 30, 2019 | 8.45% |
| Jun 30, 2019 | -25.15% |
| Mar 31, 2019 | 14.33% |
| Dec 31, 2018 | 13.44% |
| Sep 30, 2018 | -32.34% |
| Jun 30, 2018 | -30.49% |
| Mar 31, 2018 | -0.07% |
| Dec 31, 2017 | -17.09% |
| Sep 30, 2017 | -4.42% |
| Jun 30, 2017 | -13.11% |
| Mar 31, 2017 | 7.73% |
| Dec 31, 2016 | -8.21% |
| Sep 30, 2016 | -15.39% |
| Jun 30, 2016 | 15.98% |
| Mar 31, 2016 | -18.93% |
| Dec 31, 2015 | -18.11% |
| Sep 30, 2015 | -7.38% |
| Jun 30, 2015 | -39.68% |
| Mar 31, 2015 | -14.24% |
| Dec 31, 2014 | -1.13% |
| Sep 30, 2014 | -0.43% |
| Jun 30, 2014 | 83.27% |
| Mar 31, 2014 | -809.25% |
| Dec 31, 2013 | 8.20% |
| Sep 30, 2013 | -51.25% |
| Jun 30, 2013 | -117.38% |
| Mar 31, 2013 | 88.90% |
| Dec 31, 2012 | -386.85% |
| Sep 30, 2012 | -50.39% |
| Jun 30, 2012 | -10.78% |
| Mar 31, 2012 | 19.82% |
| Dec 31, 2011 | -9.23% |
| Sep 30, 2011 | 5.18% |
| Jun 30, 2011 | 16.32% |
| Mar 31, 2011 | -26.32% |
| Dec 31, 2010 | -42.19% |
| Sep 30, 2010 | 24.93% |
| Jun 30, 2010 | -2.83% |
| Mar 31, 2010 | -40.12% |
| Dec 31, 2009 | 16.38% |
| Sep 30, 2009 | 56.94% |